TYK Medicines-B (02410): Subscription Agreement for Issue of H Shares Under General Mandate Lapses

Zhito Finance APP news, TYK Medicines-B (02410) announced that regarding the licensing and collaboration with Qilu and the proposed issuance of 63.2227 million H shares to the subscribers. The subscription is subject to the fulfillment or waiver of the conditions precedent under the subscription agreement. If the conditions of the subscription are not fulfilled or waived by the revised long-stop date (i.e., September 20, 2026), the subscription agreement will be terminated. As of the date of this announcement, certain conditions precedent under the subscription agreement have not been fulfilled or waived.